Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immune responses to an additional mRNA COVID-19 booster in adults previously vaccinated with inactivated and other COVID-19 vaccines
TCTR20230811004Phase 2Completed
- Sponsor
- National Research Council of Thailand
- Start
- Jun 2023
- Modality
- Vaccines & Immunotherapeutics, mRNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics, Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 2 trial of mRNA COVID-19 vaccine in coronavirus disease 2019 (COVID-19), sponsored by National Research Council of Thailand. Primary endpoint: Immune response to mRNA COVID-19 booster. Started Jun 2023; status: completed.
02
Drugs
mRNA COVID-19 vaccine
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on TCTR20230811004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20230811004.